Immune effector cell-associated hematotoxicity following CAR-T cell therapies: insights from a large national database.

De-escalation of breast surgery for early stage breast cancer.

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan.

A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).

Immune effector cell-associated hematotoxicity following CAR-T cell therapies: insights from a large national database.

De-escalation of breast surgery for early stage breast cancer.

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan.

A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).